IRIS
BARISON, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.127
EU - Europa 4.805
AS - Asia 3.921
SA - Sud America 1.094
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 3
Totale 18.048
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.757
SG - Singapore 1.682
RU - Federazione Russa 1.452
IT - Italia 988
CN - Cina 940
BR - Brasile 886
GB - Regno Unito 802
VN - Vietnam 560
DE - Germania 542
UA - Ucraina 283
CA - Canada 274
HK - Hong Kong 238
SE - Svezia 131
DK - Danimarca 117
FR - Francia 114
IN - India 89
FI - Finlandia 85
AR - Argentina 82
PL - Polonia 77
MX - Messico 68
IL - Israele 63
TR - Turchia 60
BD - Bangladesh 55
ID - Indonesia 54
ES - Italia 53
EC - Ecuador 43
IE - Irlanda 43
NL - Olanda 39
ZA - Sudafrica 39
JP - Giappone 35
IQ - Iraq 31
AT - Austria 21
CO - Colombia 18
UZ - Uzbekistan 18
PY - Paraguay 17
AE - Emirati Arabi Uniti 16
MA - Marocco 13
PK - Pakistan 13
LT - Lituania 12
EU - Europa 11
VE - Venezuela 11
CL - Cile 10
UY - Uruguay 10
PE - Perù 9
JO - Giordania 8
KE - Kenya 8
EG - Egitto 7
MY - Malesia 7
SA - Arabia Saudita 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
IR - Iran 6
CZ - Repubblica Ceca 5
GY - Guiana 5
AZ - Azerbaigian 4
BE - Belgio 4
HN - Honduras 4
KZ - Kazakistan 4
TH - Thailandia 4
BB - Barbados 3
BY - Bielorussia 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
SI - Slovenia 3
SM - San Marino 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
KR - Corea 2
MD - Moldavia 2
NI - Nicaragua 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TL - Timor Orientale 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
KG - Kirghizistan 1
Totale 18.033
Salva come PNG Salva come JPEG
Città #
Dallas 1.512
Singapore 892
Ashburn 500
Beijing 493
Southend 444
Chicago 340
Houston 315
Chandler 314
Los Angeles 304
Moscow 287
Fairfield 252
Ann Arbor 241
Woodbridge 225
Hong Kong 208
San Mateo 200
Ho Chi Minh City 174
Wilmington 158
Seattle 150
Cambridge 129
Falls Church 129
Salt Lake City 128
The Dalles 118
New York 115
Buffalo 109
Dearborn 108
Jacksonville 108
São Paulo 102
Ottawa 100
Tampa 93
Boardman 92
Hefei 91
Hanoi 87
Pisa 81
Portsmouth 79
Stevenage 79
Munich 72
Rome 71
Dong Ket 68
Warsaw 68
Brooklyn 64
Elk Grove Village 60
Santa Clara 59
Lawrence 57
Beauharnois 56
London 55
Tel Aviv 54
Milan 50
Montreal 50
Dublin 41
Denver 35
Orem 35
Sterling 35
Istanbul 34
San Diego 34
Florence 33
Lancaster 33
Stockholm 33
Frankfurt am Main 32
Atlanta 31
Chennai 31
Poplar 31
Rio de Janeiro 31
Tokyo 31
Johannesburg 29
Phoenix 28
Boston 27
Campinas 26
Turku 26
Mexico City 25
Toronto 22
Central District 21
Montréal 21
Redwood City 21
Guayaquil 20
Miami 20
Nuremberg 19
Amsterdam 18
Helsinki 18
Lappeenranta 18
Dulles 17
Tashkent 17
Belo Horizonte 16
Genoa 16
Mumbai 16
San Francisco 16
Ankara 15
Guangzhou 15
Lucca 15
Querétaro 15
Salvador 15
Bari 14
Biên Hòa 14
Detroit 14
Palermo 14
Columbus 13
San Jose 13
Brasília 12
Council Bluffs 12
Curitiba 12
Haiphong 12
Totale 10.703
Salva come PNG Salva come JPEG
Nome #
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.510
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 657
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 310
A simple echocardiographic score to rule out cardiac amyloidosis 306
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 298
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 285
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 279
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 279
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 278
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 276
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 268
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 267
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 262
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 261
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 260
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 258
A simple echocardiographic score to rule out cardiac amyloidosis 257
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 257
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 240
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 236
Sex-related differences in chronic heart failure 234
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 233
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 230
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 226
Update sui biomarcatori nello scompenso cardiaco. 220
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 218
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 215
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 213
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 212
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 209
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 207
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 207
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 206
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 205
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 202
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 195
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 194
Cardiovascular disease and COVID-19: les liaisons dangereuses 191
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 188
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 183
Role of Imaging in Cardiomyopathies 179
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 179
Cardiac magnetic resonance in patients with muscular dystrophies 179
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 177
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 175
Valvular heart disease in patients with cardiac amyloidosis 170
Perspectives in noninvasive imaging for chronic coronary syndromes 169
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 168
Molecular autopsy of sudden cardiac death in the genomics era 168
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 166
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 165
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 164
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 162
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 162
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 161
Colchicine for the treatment of coronary artery disease 157
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 157
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 154
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 153
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 151
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 151
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 149
Troponin in non-ischaemic dilated cardiomyopathy 147
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 145
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 145
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 142
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 140
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 134
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 133
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 133
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 133
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 131
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 128
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 126
Treatment of cardiac transthyretin amyloidosis: an update 124
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 121
Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry 117
Multimodality Imaging in a Patient With MINOCA and Anomalous Coronary Artery 116
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 110
Partial Lipodystrophy and LMNA p.R545H Variant 105
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 105
The unbearable underreporting of comorbidities in heart failure clinical trials 101
The Barthel Index in elderly acute heart failure patients. Frailty matters 99
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 95
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 94
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 93
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 93
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 90
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 85
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 78
null 29
European task force reclassification of dilated and non-dilated cardiomyopathies identifies a high arrhythmic-risk overlap phenotype 28
Prognostic role of updated Lake Louise criteria for the diagnosis of acute myocarditis (ITAMY-mapping study) 22
Totale 18.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.025 0 0 0 0 0 179 136 74 160 112 171 193
2021/20221.102 122 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/20255.130 45 54 208 67 166 214 505 970 327 915 932 727
2025/20267.007 736 1.666 1.365 1.555 1.265 420 0 0 0 0 0 0
Totale 18.190